225 related articles for article (PubMed ID: 26856461)
1. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
Xie W; Zheng F; Zhong B; Song X
J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Kamal AK; Naqvi I; Husain MR; Khealani BA
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD008076. PubMed ID: 21249700
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
[TBL] [Abstract][Full Text] [Related]
8. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
9. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
Kim SM; Jung JM; Kim BJ; Lee JS; Kwon SU
Stroke; 2019 Dec; 50(12):3503-3511. PubMed ID: 31607242
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
[TBL] [Abstract][Full Text] [Related]
12. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
13. [Antiplatelet therapy: update in secondary stroke prevention].
Uchiyama S
Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.
Huang HP; Lin WH; Chen SG; Chen LZ; Chen MY; Che CH
Mol Neurobiol; 2017 Mar; 54(2):1456-1466. PubMed ID: 26846361
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
[TBL] [Abstract][Full Text] [Related]
20. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.
Paciaroni M; Ince B; Hu B; Jeng JS; Kutluk K; Liu L; Lou M; Parfenov V; Wong KSL; Zamani B; Paek D; Min Han J; Del Aguila M; Girotra S
Cardiovasc Ther; 2019; 2019():1607181. PubMed ID: 31867054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
